Home / Recalls / PD-Rx Pharmaceuticals, Inc. / D-0559-2023

D-0559-2023 Class II Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

Recall Details

Product Type: Drugs
Report Date: May 10, 2023
Initiation Date: April 6, 2023
Termination Date: April 30, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 186 bottles

Product Description

Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127, NDC 43063-0587-90

Reason for Recall

CGMP deviations.

Distribution Pattern

Nationwide in the US.

Code Information

Lots: A22B45 Exp. 01/31/24; C22A73, E22E41, C22D28, F22B68, G22A29, H22B97, K22A36 Exp. 03/31/24; K22B99, A23D07, B23B25 Exp. 10/31/24; B23B55 Exp. 06/30/25

Other recalls by PD-Rx Pharmaceuticals, Inc.

D-0163-2025 Class II — DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceu (December 4, 2024)
D-0561-2023 Class II — Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg (April 6, 2023)
D-0558-2023 Class II — Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pk (April 6, 2023)
D-0560-2023 Class II — Simvastatin USP 20 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg (April 6, 2023)
D-0557-2023 Class II — Montelukast Sodium USP, 10 mg, 30 count-bottles, Rx only, Intas Pharm, Limited A (April 6, 2023)
D-1161-2022 Class II — Losartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and (June 6, 2022)
D-1162-2022 Class II — Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and (June 6, 2022)
D-1163-2022 Class II — Losartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed an (June 6, 2022)
D-0060-2021 Class II — metformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklah (October 6, 2020)
D-0059-2021 Class II — metformin HCL ER 500 mg, a) 30 tablets NDC: 72789-009-30; b) 60 tablets NDC: 727 (October 6, 2020)